Global Dextran Market Growth 2025-2031
The global Dextran market size is predicted to grow from US$ 254 million in 2025 to US$ 365 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.
Dextran is a non-ionic branched polysaccharide, appearing as a white powder. Native dextran is prepared by fermentation of sugar, followed by subsequent harvest and purification. Native Dextran is then modified by hydrolysis and separation into the desired molecular weight.
The global core manufacturers of Dextran include Pharmacosmos, PK Chemicals and Jinyang Biological Pharmaceutical. The top three companies have about 90 per cent of the market. Asia Pacific is the world's largest dextran market with a market share of about 59%, followed by Europe and North America with a market share of 22% and 18%, respectively. In terms of product type, Dextran 40 is the largest segment with approximately 40% market share, while in terms of applications, solutions for injection and infusion is the largest downstream segment with approximately 59% market share.
LP Information, Inc. (LPI) ' newest research report, the “Dextran Industry Forecast” looks at past sales and reviews total world Dextran sales in 2024, providing a comprehensive analysis by region and market sector of projected Dextran sales for 2025 through 2031. With Dextran sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dextran industry.
This Insight Report provides a comprehensive analysis of the global Dextran landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dextran portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dextran market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dextran and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dextran.
This report presents a comprehensive overview, market shares, and growth opportunities of Dextran market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Dextran 20
Dextran 40
Dextran 60
Dextran 70
Others
Segmentation by Application:
Solutions for Injection and Infusion
Dextran Derivative
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pharmacosmos
PK Chemicals
Meito Sangyo
Polydex Pharm
Jinyang Biological Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dextran market?
What factors are driving Dextran market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dextran market opportunities vary by end market size?
How does Dextran break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.